COOL — Core One Labs Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual cashflow statement for Core One Labs, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | C2019 December 31st | 2020 December 31st | 2021 December 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 15 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.2 | -10.7 | -46.9 | -37.1 | -20 |
| Depreciation | |||||
| Non-Cash Items | 3.2 | -2.14 | 41.2 | 30.6 | 19.8 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.256 | 1.42 | 1.98 | 1.8 | -2.62 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10.2 | -8.12 | -3.71 | -4.64 | -2.77 |
| Capital Expenditures | -4.81 | — | — | -0.009 | -0.034 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.87 | 1.43 | -0.315 | 1.3 | 0.263 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.68 | 1.43 | -0.315 | 1.29 | 0.229 |
| Financing Cash Flow Items | — | 0.13 | 0.015 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.4 | 6.34 | 4.43 | 3.58 | 2.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.3 | -0.335 | 0.412 | 0.235 | -0.137 |